However, ERO1 loss of function is not fully compensated by PRDX4 and other oxidases: indeed, in previous work, we demonstrated a selective impairment of VEGFA-mediated angiogenesis in ERO1-devoid breast cancer under hypoxic conditions [20]. This evidence concerns the gene PRDX4 and breast cancer.